Bayer enters COVID-19 vaccine row with three suits against major drugmakers | Americas | Life Sciences Intellectual Property Review

Litigation, Intellectual Property News

8 January 2026NewsAmericasLiz Hockley. Bayer enters COVID-19 vaccine row with three suits against major drugmakers.